Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ligand Pharm (NQ: LGND ) 105.86 -0.68 (-0.64%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 82,793 Open 106.75 Bid (Size) 105.86 (2) Ask (Size) 106.07 (2) Prev. Close 106.54 Today's Range 105.55 - 108.83 52wk Range 49.24 - 112.12 Shares Outstanding 16,676,532 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference August 20, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Looking Into Ligand Pharmaceuticals's Recent Short Interest August 16, 2024 Via Benzinga Performance YTD +46.40% +46.40% 1 Month -2.66% -2.66% 3 Month +24.61% +24.61% 6 Month +25.50% +25.50% 1 Year +64.46% +64.46% More News Read More Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review August 09, 2024 Via Investor's Business Daily LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 Via InvestorPlace Assessing Ligand Pharmaceuticals: Insights From 6 Financial Analysts July 30, 2024 Via Benzinga What 4 Analyst Ratings Have To Say About Ligand Pharmaceuticals June 28, 2024 Via Benzinga Halozyme And Ligand — Two Leading Biotechs — Smash Quarterly Forecasts August 06, 2024 Via Investor's Business Daily Ligand Reports Second Quarter 2024 Financial Results August 06, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024 July 23, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire 5 Best Short-Term Stocks to Consider Investing In July 10, 2024 Via MarketBeat Ligand to Acquire APEIRON Biologics AG for $100 Million July 08, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Lifecore Biomedical Announces Cooperation Agreement with 22NW July 01, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years June 27, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults June 18, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Participate in Upcoming Investor Conferences May 23, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire 3 Magnificent Growth Stocks to Buy Hand Over Fist May 22, 2024 Via The Motley Fool Topics Economy Exposures Interest Rates 3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off May 20, 2024 Via InvestorPlace LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Ligand Reports First Quarter 2024 Financial Results May 07, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement May 07, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Don't Overlook These Top Medical Stocks As Q1 Earnings Approach May 07, 2024 Via Talk Markets Ligand to Report First Quarter 2024 Financial Results on May 7, 2024 April 23, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire 7 Small-Cap Stocks for the Thinking Speculator April 08, 2024 Via InvestorPlace Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference April 08, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™ April 03, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
